Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease

Otology and Neurotology

Volumn 27, Issue 6, 2006, Pages 896-900

  Horii, Arata ^a   Saika, Takanori ^a   Uno, Atsuhiko ^a   Nishiike, Suetaka ^a   Mitani, Kenji ^a   Nishimura, Masato ^a   Kitahara, Tadashi ^a   Fukushima, Munehisa ^a   Nakagawa, Aya ^a   Masumura, Chisako ^a   Sasaki, Tomo ^a   Kizawa, Kaoru ^a   Kubo, Takeshi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Caloric response; Electrocochleography; Gentamicin; Hearing; M ni re's disease; Post head shake nystagmus; Vasopressin

Indexed keywords

GENTAMICIN; VASOPRESSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTROCOCHLEOGRAPHY; FEMALE; HEARING LOSS; HUMAN; MALE; MENIERE DISEASE; NEURECTOMY; NYSTAGMUS; PARESIS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; TREATMENT OUTCOME; VERTIGO; VESTIBULAR DISORDER;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AUDIOMETRY, EVOKED RESPONSE; FEMALE; GENTAMICINS; HEARING LOSS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MENIERE'S DISEASE; MIDDLE AGED; NYSTAGMUS, PATHOLOGIC; PROSPECTIVE STUDIES; TYMPANIC MEMBRANE; VERTIGO; VESTIBULAR FUNCTION TESTS;

EID: 33748286946     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000227663.79210.c1     Document Type: Article

References (19)

1. Gates GA. Ménière's disease: medical therapy. In: Harris JP, ed. Ménière's Disease. The Hague: Kugler Publications, 1999:329-40.
2. Jackson CG, Dickins JR, McMenomey SO, et al. Endolymphatic system shunting: a long-term profile of the Denver Inner Ear Shunt. Am J Otolaryngol 1996;17:85-8.
3. Blakley BW. Update on intratympanic gentamicin for Méniè re's disease. Laryngoscope 2000;110:236-40.
4. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Ménière's disease. Laryngoscope 2000;110:1298-305.
5. Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome. Otol Neurotol 2001;22:210-4.
6. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 2004;25:544-52.
7. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Ménière's disease: a meta-analysis. Laryngoscope 2004;114:2085-91.
8. Light JP, Silverstein H. Transtympanic perfusion: indications and limitations. Curr Opin Otolaryngol Head Neck Surg 2004;12:378-83.
9. Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol 2005;67:259-84.
10. Committee on Hearing and Equilibrium. Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
11. Kaasinen S, Pyykko I, Ishizaki H, Aalto H. Intratympanic gentamicin in Ménière's disease. Acta Otolaryngol 1998;118:294-8.
12. Perez N, Martin E, Garcia-Tapia R. Intratympanic gentamicin for intractable Ménière's disease. Laryngoscope 2003;113:456-64.
13. Light JP, Silverstein H, Jackson LE. Gentamicin perfusion vestibular response and hearing loss. Otol Neurotol 2003;24:294-8.
14. de Waele C, Meguenni R, Freyss G, et al. Intratympanic gentamicin injections for Ménière disease: vestibular hair cell impairment and regeneration. Neurology 2002;59:1442-4.
15. Pender DJ. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol 1985;6:358-67.
16. Adamonis J, Stanton SG, Cashman MZ, Mattan K, Nedzelski JM, Chen JM. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report. Am J Otolaryngol 2000;21:534-42.
17. Cureoglu S, Schachern PA, Paparella MM. Effect of parenteral aminoglycoside administration on dark cells in the crista ampullaris. Arch Otolaryngol Head Neck Surg 2003;129:626-8.
18. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20.
19. Horii A, Kitahara T, Uno A, et al. Vestibular function and vasopressin. Acta Otolaryngol Suppl 2004;553:50-3.